Drug Alert: Taro Pharmaceuticals Issues Voluntary Nationwide Recall of Lamotrigine 100 mg tablets

On January 10, 2020, the U.S. Food and Drug Administration (FDA) published a company alert about a voluntary recall of lamotrigine 100 mg tablets from Taro Pharmaceuticals.

• Lamotrigine 100 mg tablets from lot # 331771 are being recalled due to possible contamination with another medicine.
• People taking lamotrigine 100 mg tablets should call their pharmacy to check if their medicine is affected.
• Lamotrigine from the affected lot can be taken back to the pharmacy and ask for a new supply.
• Problems with any medication can be reported to the FDA Medwatch Program.

Important

Please do NOT stop taking your seizure medicine suddenly. If you suspect you may have lamotrigine from the recalled lot, please call your pharmacy and get a new supply of lamotrigine.

Editors note: Originally published January 12, 2020; republished February 21, 2020, to highlight important information